Released on Nov 12, 2019

Take Action Now: Urge your Legislators to Cosponsor the Safe Step Act!

A National Day of Advocacy
Ask Congress to Ensure Timely Access to Medications for Your Patients 

TAKE ACTION NOW!

Today members from 19 national medical organization, several of which are GI-related, are participating in a National Day of Advocacy to call attention the importance of patients having timely access to Medications.

Pending in the U.S. Senate and House of Representatives is a bipartisan bill that has the potential to improve patient access to medications for the treatment of inflammatory bowel and other gastrointestinal diseases.

The “Safe Step Act” (S.2546/H.R.2279) creates a clear, timely and transparent process for a patient or physician to request an exception to step therapy protocols in certain situations. Step therapy is a tactic used by insurance companies that requires a patient to try and fail on their preferred medications before covering the therapy prescribed by their health care provider.

The legislation outlines situations in which a group health plan must grant an exception to “fail first” protocols, including if an application clearly demonstrates:

  • Patient already tried and failed on the required drug
  • Required drug is reasonably expected to be ineffective
  • Required drug will cause harm to the patient
  • Required drug will prevent a patient from working or fulfilling daily activities
  • Patient is stable on his/her current medication

The bill also requires that a request for an exception to step therapy be answered by the insurance company within three days, and in less than 24 hours for urgent situations.

The “Safe Step Act” is good legislation that deserves Congress' attention.  Advancing the bill requires a strong show of support by elected officials. The more cosponsors a piece of legislation has, the more likely it is to receive a vote.

TAKE ACTION NOW!  Tell your members of Congress why the “Safe Step Act” is important to patients and ask for their cosponsorship.

Social Media

Can we post to our Facebook, Twitter, and Indeed social media accounts. Camille will be providing some additional social media. 

Hashtags:  #SafeStepAct and #ReformStepTherapy

Link to our Action Alert:  http://www.cqrcengage.com/asge/app/onestep-write-a-letter?3&engagementId=503306

Below are some thoughts: 

TAKE ACTION NOW!  Tell your members of Congress why the “Safe Step Act” is important to patients and ask for their cosponsorship.

Facebook: 

Step therapy is a tool used by health insurers that requires patients to fail first on a preferred treatment before they can access treatments prescribed by their doctors. If left unchecked, the practice can impede the doctor-patient relationship and cause serious harm to patients. The Safe Step Act establishes important guardrails that protect patients when step therapy is mandated by establishing a transparent appeals process and an expedited review for at risk-patients.

The Safe Step Act provides a clear, timely and transparent exceptions process for step therapy protocols in certain situations, including when the required drug could cause harm to the patient or when the patient is stable on his or her current medication. The “Safe Step Act” is good legislation that deserves Congress' attention.  Contact your legislators today.  TAKE ACTION NOW! 

Step therapy requirements often interfere with evidence-based medicine and physician decision-making.  Ensure that patients aren’t blocked from accessing proper treatment in a timely manner. Tell your legislators to cosponsor the Safe Step Act. TAKE ACTION NOW!

TAKE ACTION NOW!  Tell your legislators to support  the “Safe Step Act” (S.2546/H.R. 2279). 

Social Media: Visit the websites for each of your U.S. Senators and House member to find their social media pages,  and tag them in your posts. Most offices have their social media listed at the bottom of their website homepages.

The templates below are targeted for Twitter, but you can customize them for any platform you prefer (Facebook, Instagram, LinkedIn, etc.):

@_______, Please cosponsor the #SafeStepAct (S. 2546 for Senate | H.R. 2279 for House). Protect patient access and #ReformStepTherapy

Step therapy impedes the doctor-patient relationship and makes it harder for patients to access essential treatment. Congress must #ReformStepTherapy and pass the #SafeStepAct

For the post above, link to our alert http://www.cqrcengage.com/asge/app/onestep-write-a-letter?3&engagementId=503306

 Example from another partner

National Day of Advocacy 2019


About Gastrointestinal Endoscopy
Gastrointestinal endoscopic procedures allow the gastroenterologist to visually inspect the upper gastrointestinal tract (esophagus, stomach and duodenum) and the lower bowel (colon and rectum) through an endoscope, a thin, flexible device with a lighted end and a powerful lens system. Endoscopy has been a major advance in the treatment of gastrointestinal diseases. For example, the use of endoscopes allows the detection of ulcers, cancers, polyps and sites of internal bleeding. Through endoscopy, tissue samples (biopsies) may be obtained, areas of blockage can be opened and active bleeding can be stopped. Polyps in the colon can be removed, which has been shown to prevent colon cancer.

About the American Society for Gastrointestinal Endoscopy
Since its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence and innovation in gastrointestinal endoscopy. ASGE, with more than 15,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education. Visit www.asge.org and www.screen4coloncancer.org for more information and to find a qualified doctor in your area.

American Society for Gastrointestinal Endoscopy
3300 Woodcreek Drive Downers Grove, IL 60515
P (630) 573-0600
F (630) 963-8332
 www.asge.org
 www.screen4coloncancer.org

Media Contact

Andrea Lee
Director of Marketing and Communications
630.570.5603
ALee@asge.org